Wednesday, December 21, 2016
Viewpoint Molecular Targeting, founded with the support of UI Ventures, was selected by the National Cancer Institute (NCI) to be a part of the business accelerator program I-Corps in 2017. Read more online.
Viewpoint Molecular Targeting, founded with the support of UI Ventures, was selected by the National Cancer Institute (NCI) to be a part of the business accelerator program I-Corps in 2017. Read more online.